# Phathom Pharmaceuticals, Inc.: Form 8-K, filed May 30, 2023

- Company: [Phathom Pharmaceuticals, Inc.](/companies/phat.md) (CIK 1783183)
- Form: 8-K
- Filed: 2023-05-30
- Accepted by EDGAR: May 30, 2023, 17:16 ET
- Period: 2023-05-25
- Accession: 0001193125-23-156713
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1783183/000119312523156713/d487635d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1783183/000119312523156713/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1783183/000119312523156713/d487635d8k.htm

Filed May 30, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-156713. Last ingested by Listed: Nov 11, 2026, 03:04 ET. No prices; not investment advice.
